Completed OBSERVATIONAL NCT04742504

Interaction Between Benralizumab and Basophils in Eosinophilic Asthma (BASEAS)

Interaction Between Benralizumab and Basophils in Eosinophilic Asthma. Discovering a New Role of an Old Asthma Player: BASEAS STUDY (Basophils in Eosinophilic Asthma)

Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Conditions Asthma; Eosinophilic

Interventions BENRALIZUMAB

Updated 7 times since 2021 Last updated: Oct 13, 2023 Started: Sep 7, 2021 Primary completion: Oct 1, 2023 Completion: Oct 13, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04742504, this observational or N/A phase trial focuses on Asthma; Eosinophilic and remains completed. Sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, it has been updated 7 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Nov 2023 — Jul 2024 [monthly]

Completed

Status: Unknown Status → Completed
Sep 2023 — Nov 2023 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
Dec 2021 — Sep 2023 [monthly]

Not Yet Recruiting

▶ Show 2 earlier versions

Sep 2021 — Dec 2021 [monthly]

Not Yet Recruiting
Mar 2021 — Sep 2021 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Data source: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain